Rare Disease Day 2020

Each year last day of February is marked as the Rare Disease Day. It is a great and a very meaningful opportunity to raise awareness about conditions that are rare i.e. affect fewer than 1 in 1,500 people in the United States or fewer than 1 in 2,000 people in the EU. Nevertheless, they are no less important.

GCT has contributed to the development of a number medical products for rare diseases and orphan drugs in hematology, dermatology, rare CNS indications, genetic disorders, respiratory, metabolic, cancer etc. Currently, we are conducting a pediatric study in patients with a rare neurological disorder. All of us at GCT look forward to seeing the positive impact of the drug on the young patients that participate in the trial and on their families.

Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

About

GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login

 

GCT

© 2001—2020 Global Clinical Trials, LLC

All rights reserved.